Ceftazidime/Avibactam Monotherapy Versus Other Antibiotics: Where Do We Stand? [PDF]
Vougiouklakis G +5 more
europepmc +1 more source
Real-world usage, effectiveness, and microbiological features of ceftazidime-avibactam in clinical practice in China. [PDF]
Qin X +20 more
europepmc +1 more source
Prevalence, Antimicrobial Susceptibility, and Molecular Characteristics of Ceftazidime-Avibactam-Resistant <i>Klebsiella pneumoniae</i> in a Chinese Hospital. [PDF]
Li J +7 more
europepmc +1 more source
Global Antimicrobial Stewardship: Challenges and Successes from Frontline Stewards [PDF]
Debra A. Goff, Michael J. Rybak
core +1 more source
Ceftazidime/avibactam and aztreonam combined with an aminoglycoside combat metallo-β-lactamase-producing <i>Klebsiella pneumoniae</i>. [PDF]
Karunanidhi A +10 more
europepmc +1 more source
Ceftazidime-avibactam for multidrug and pandrug-resistant gram-negative infections in critically Ill children: a single-center pediatric ıntensive care experience. [PDF]
Havan M +11 more
europepmc +1 more source
Ceftazidime-Avibactam in Critically Ill Patients: A Multicenter Observational Study. [PDF]
Silvia O +12 more
europepmc +1 more source
Antimicrobial Susceptibility of Ceftazidime-Avibactam in Clinical Isolates of Carbapenemase-Producing Enterobacterales. [PDF]
Jain S, Vyas A, Chaturvedi P.
europepmc +1 more source
Co-Administration Dosing of Ceftazidime-Avibactam and Aztreonam in Patients with Varying Renal Function for Carbapenem-Resistant Enterobacterales Infections via Monte Carlo Simulation. [PDF]
Hemapanpairoa J +3 more
europepmc +1 more source
Ceftazidime-Avibactam: A Retrospective Analysis of Multicenter Real-World Data and Factors Affecting Mortality. [PDF]
Aktuğ Demir N +22 more
europepmc +1 more source

